Volume 14 Supplement 1

Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

Poster presentation
Open Access

Unfolded protein response mediator, the IRE1α-XBP1 pathway is involved in osteoblast differentiation

  • Takahide Tohmonda1, 2,
  • Kazuhiro Chiba2,
  • Yoshiaki Toyama2 and
  • Keisuke Horiuchi1, 2
Arthritis Research & Therapy201214(Suppl 1):P70

https://doi.org/10.1186/ar3671

©  Tohmonda et al.; licensee BioMed Central Ltd. 2012

Published: 29 February 2012

Background

To maintain the bone strength and functions, the balance between bone resorption and bone formation has to be tightly regulated. However, under certain pathological conditions, including osteoporosis and rheumatoid arthritis, the equilibrium gets disrupted, resulting in a severe bone loss. Recent studies have shown that signaling molecules involved in the unfolded protein response (UPR) are potentially involved in the coupling of bone resorption and bone formation [1–3]. In the present study, we investigated the roles of UPR mediator, the IRE1α-XBP1 pathway in osteoblast differentiation.

Materials and methods

To induce osteoblast differentiation in vitro, we used recombinant human BMP-2 and mouse embryonic fibroblasts (MEFs) obtained from wild-type and Ire1 -/- embryos. Small interfering RNA-mediated gene silencing was used to suppress the expression of the target molecules of IRE1 (XBP1 and TRAF2) in wild-type MEFs. Osteoblast differentiation was evaluated by analyzing the expression levels of the transcripts for osteoblast differentiation markers (Runx2, Osterix, Osteoclacin and type I collagen) and alkaline-phosphatase activity.

Results

We found that UPR is induced during osteoblast differentiation in in vitro and ex vivo experiments. Most importantly, Ire -/- MEFs and Xbp1-silenced MEFs were defective in BMP2-induced osteoblast differentiation, indicating that the IRE1α-XBP1 pathway is essential for the maturation of osteoblasts. Furthermore, we found that UPR induces transcription of Osterix (a transcription factor indispensable for bone formation) via the IRE1α-XBP1 pathway, and that XBP1 directly binds to the promoter region of the Osterix gene and functions as a transcription factor. Taken together, the present study indicates that the UPR induced during osteoblast differentiation stimulates Osterix transcription through the IRE1α-XBP1 pathway.

Conclusions

The present study shows that the IRE1α-XBP1 pathway is a critical component of osteoblast differentiation. Since the IRE1α-XBP1 is also involved in the production of a potent regulator for osteoclast differentiation, interferon beta [1, 2], the IRE1α-XBP1 pathway may be an attractive molecular target in modulating the equilibrium between bone formation and bone resorption under pathological conditions.

Authors’ Affiliations

(1)
Department of Anti-aging Orthopedic Research, School of Medicine, Keio University
(2)
Department of Orthopedic Surgery, School of Medicine, Keio University

References

  1. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T: RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature. 2002, 416: 744-9. 10.1038/416744a.View ArticlePubMedGoogle Scholar
  2. Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, Colbert RA: Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1. Eur J Immunol. 2008, 38: 1194-203. 10.1002/eji.200737882.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Murakami T, Saito A, Hino S, Kondo S, Kanemoto S, Chihara K, Sekiya H, Tsumagari K, Ochiai K, Yoshinaga K, Saitoh M, Nishimura R, Yoneda T, Kou I, Furuichi T, Ikegawa S, Ikawa M, Okabe M, Wanaka A, Imaizumi K: Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation. Nat Cell Biol. 2009, 11: 1205-11. 10.1038/ncb1963.View ArticlePubMedGoogle Scholar

Copyright

© Tohmonda et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement